• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样蛋白网络拓扑特征描述了痴呆前期阶段阿尔茨海默病的进展。

Amyloid Network Topology Characterizes the Progression of Alzheimer's Disease During the Predementia Stages.

机构信息

Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden.

Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.

出版信息

Cereb Cortex. 2018 Jan 1;28(1):340-349. doi: 10.1093/cercor/bhx294.

DOI:10.1093/cercor/bhx294
PMID:29136123
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6454565/
Abstract

There is increasing evidence showing that the accumulation of the amyloid-β (Aβ) peptide into extracellular plaques is a central event in Alzheimer's disease (AD). These abnormalities can be detected as lowered levels of Aβ42 in the cerebrospinal fluid (CSF) and are followed by increased amyloid burden on positron emission tomography (PET) several years before the onset of dementia. The aim of this study was to assess amyloid network topology in nondemented individuals with early stage Aβ accumulation, defined as abnormal CSF Aβ42 levels and normal Florbetapir PET (CSF+/PET-), and more advanced Aβ accumulation, defined as both abnormal CSF Aβ42 and Florbetapir PET (CSF+/PET+). The amyloid networks were built using correlations in the mean 18F-florbetapir PET values between 72 brain regions and analyzed using graph theory analyses. Our findings showed an association between early amyloid stages and increased covariance as well as shorter paths between several brain areas that overlapped with the default-mode network (DMN). Moreover, we found that individuals with more advanced amyloid accumulation showed more widespread changes in brain regions both within and outside the DMN. These findings suggest that amyloid network topology could potentially be used to assess disease progression in the predementia stages of AD.

摘要

越来越多的证据表明,β淀粉样蛋白(Aβ)肽在细胞外斑块中的积累是阿尔茨海默病(AD)的中心事件。这些异常可以通过脑脊液(CSF)中 Aβ42 水平降低来检测,并在痴呆症发作前几年通过正电子发射断层扫描(PET)显示出淀粉样蛋白负担增加。本研究旨在评估早期 Aβ 积累的非痴呆个体的淀粉样蛋白网络拓扑结构,定义为 CSF Aβ42 水平异常和 Florbetapir PET 正常(CSF+/PET-),以及更严重的 Aβ 积累,定义为 CSF Aβ42 和 Florbetapir PET 均异常(CSF+/PET+)。使用 72 个大脑区域之间的平均 18F-Florbetapir PET 值的相关性构建淀粉样蛋白网络,并使用图论分析进行分析。我们的研究结果表明,早期淀粉样蛋白阶段与几个大脑区域之间的协方差增加以及路径缩短有关,这些区域与默认模式网络(DMN)重叠。此外,我们发现,具有更严重淀粉样蛋白积累的个体在 DMN 内外的大脑区域显示出更广泛的变化。这些发现表明,淀粉样蛋白网络拓扑结构可能可用于评估 AD 痴呆前阶段的疾病进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e2/6454565/70c7dd0a2563/bhx294f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e2/6454565/12fc6da3127b/bhx294f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e2/6454565/bd98ce58cc14/bhx294f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e2/6454565/357d938f78e3/bhx294f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e2/6454565/f13e11c27b65/bhx294f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e2/6454565/70c7dd0a2563/bhx294f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e2/6454565/12fc6da3127b/bhx294f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e2/6454565/bd98ce58cc14/bhx294f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e2/6454565/357d938f78e3/bhx294f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e2/6454565/f13e11c27b65/bhx294f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e2/6454565/70c7dd0a2563/bhx294f05.jpg

相似文献

1
Amyloid Network Topology Characterizes the Progression of Alzheimer's Disease During the Predementia Stages.淀粉样蛋白网络拓扑特征描述了痴呆前期阶段阿尔茨海默病的进展。
Cereb Cortex. 2018 Jan 1;28(1):340-349. doi: 10.1093/cercor/bhx294.
2
Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.临床前阿尔茨海默病各阶段皮质和皮质下淀粉样蛋白负荷模式
J Int Neuropsychol Soc. 2016 Nov;22(10):978-990. doi: 10.1017/S1355617716000928.
3
Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.临床中应用脑脊液β-淀粉样蛋白 42 检测脑淀粉样蛋白准确性的研究:对淀粉样蛋白正电子发射断层扫描的交叉验证。
JAMA Neurol. 2014 Oct;71(10):1282-9. doi: 10.1001/jamaneurol.2014.1358.
4
Rate of β-amyloid accumulation varies with baseline amyloid burden: Implications for anti-amyloid drug trials.β-淀粉样蛋白的积累速度随基线淀粉样蛋白负担的变化而变化:对抗淀粉样蛋白药物试验的影响。
Alzheimers Dement. 2018 Nov;14(11):1387-1396. doi: 10.1016/j.jalz.2018.05.013. Epub 2018 Jul 4.
5
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.氟替卡匹尔PET tau蛋白结合与淀粉样蛋白负荷、临床诊断、年龄和认知之间的关系。
Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.
6
Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid.比较正电子发射断层扫描成像与β-淀粉样蛋白的脑脊液测量。
Ann Neurol. 2013 Dec;74(6):826-36. doi: 10.1002/ana.23908.
7
CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort.脑脊液生物标志物与淀粉样 PET 检测在 MCI 队列中的一致性和诊断准确性。
Acta Neurol Belg. 2019 Sep;119(3):445-452. doi: 10.1007/s13760-019-01112-8. Epub 2019 Mar 7.
8
Memory self-awareness in the preclinical and prodromal stages of Alzheimer's disease.阿尔茨海默病临床前期和前驱期的记忆自我意识
Neuropsychologia. 2017 May;99:343-349. doi: 10.1016/j.neuropsychologia.2017.04.002. Epub 2017 Apr 3.
9
Longitudinal validity of PET-based staging of regional amyloid deposition.基于正电子发射断层扫描的局部淀粉样沉积分期的纵向有效性。
Hum Brain Mapp. 2020 Oct 15;41(15):4219-4231. doi: 10.1002/hbm.25121. Epub 2020 Jul 10.
10
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.采用氟[18F]氟比他滨 PET 评估淀粉样蛋白-β与 18 个月认知衰退的相关性:一项多中心研究。
Neurology. 2012 Oct 16;79(16):1636-44. doi: 10.1212/WNL.0b013e3182661f74. Epub 2012 Jul 11.

引用本文的文献

1
A novel method for PET connectomics guided by fibre-tracking MRI: Application to Alzheimer's disease.一种基于纤维追踪 MRI 的新型 PET 连接组学方法:在阿尔茨海默病中的应用。
Hum Brain Mapp. 2024 Mar;45(4):e26659. doi: 10.1002/hbm.26659.
2
Multiplex core of the human brain using structural, functional and metabolic connectivity derived from hybrid PET-MR imaging.利用基于混合PET-MR成像的结构、功能和代谢连接构建人类大脑的多重核心。
Front Neuroimaging. 2023 Aug 14;2:1115965. doi: 10.3389/fnimg.2023.1115965. eCollection 2023.
3
The effects of noninvasive brain stimulation on cognitive function in patients with mild cognitive impairment and Alzheimer's disease using resting-state functional magnetic resonance imaging: A systematic review and meta-analysis.

本文引用的文献

1
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity.β-淀粉样蛋白最早在默认模式网络中积累,并同时影响大脑的连接。
Nat Commun. 2017 Oct 31;8(1):1214. doi: 10.1038/s41467-017-01150-x.
2
BRAPH: A graph theory software for the analysis of brain connectivity.BRAPH:一款用于分析脑连接性的图论软件。
PLoS One. 2017 Aug 1;12(8):e0178798. doi: 10.1371/journal.pone.0178798. eCollection 2017.
3
The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.
静息态功能磁共振成像指导下非侵入性脑刺激对轻度认知障碍和阿尔茨海默病患者认知功能的影响:系统评价和荟萃分析。
CNS Neurosci Ther. 2023 Nov;29(11):3160-3172. doi: 10.1111/cns.14314. Epub 2023 Jun 22.
4
Topologically convergent and divergent large scale complex networks among Alzheimer's disease spectrum patients: A systematic review.阿尔茨海默病谱系患者中拓扑收敛和发散的大规模复杂网络:一项系统综述。
Heliyon. 2023 Apr 8;9(4):e15389. doi: 10.1016/j.heliyon.2023.e15389. eCollection 2023 Apr.
5
Individualized network analysis: A novel approach to investigate tau PET using graph theory in the Alzheimer's disease continuum.个体化网络分析:一种在阿尔茨海默病连续体中使用图论研究tau正电子发射断层扫描的新方法。
Front Neurosci. 2023 Mar 2;17:1089134. doi: 10.3389/fnins.2023.1089134. eCollection 2023.
6
Brain connectomics: time for a molecular imaging perspective?脑连接组学:是时候从分子影像学角度来看待了吗?
Trends Cogn Sci. 2023 Apr;27(4):353-366. doi: 10.1016/j.tics.2022.11.015. Epub 2023 Jan 6.
7
The trend of disruption in the functional brain network topology of Alzheimer's disease.阿尔茨海默病患者大脑功能网络拓扑结构破坏的趋势。
Sci Rep. 2022 Sep 2;12(1):14998. doi: 10.1038/s41598-022-18987-y.
8
Identifying the individual metabolic abnormities from a systemic perspective using whole-body PET imaging.从整体系统角度利用全身正电子发射断层扫描成像技术识别个体代谢异常。
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2994-3004. doi: 10.1007/s00259-022-05832-7. Epub 2022 May 14.
9
Multiplex Connectome Changes across the Alzheimer's Disease Spectrum Using Gray Matter and Amyloid Data.使用灰质和淀粉样蛋白数据对阿尔茨海默病谱的多重连接组学变化进行研究。
Cereb Cortex. 2022 Aug 3;32(16):3501-3515. doi: 10.1093/cercor/bhab429.
10
Relationships between frontal metabolites and Alzheimer's disease biomarkers in cognitively normal older adults.认知正常老年人额皮质代谢物与阿尔茨海默病生物标志物的关系。
Neurobiol Aging. 2022 Jan;109:22-30. doi: 10.1016/j.neurobiolaging.2021.09.016. Epub 2021 Sep 20.
阿尔茨海默病神经影像学计划3:临床试验改进的持续创新。
Alzheimers Dement. 2017 May;13(5):561-571. doi: 10.1016/j.jalz.2016.10.006. Epub 2016 Dec 5.
4
Differences in Aβ brain networks in Alzheimer's disease and healthy controls.阿尔茨海默病与健康对照者大脑中β淀粉样蛋白网络的差异。
Brain Res. 2017 Jan 15;1655:77-89. doi: 10.1016/j.brainres.2016.11.019. Epub 2016 Nov 17.
5
Network abnormalities and interneuron dysfunction in Alzheimer disease.阿尔茨海默病中的网络异常与中间神经元功能障碍。
Nat Rev Neurosci. 2016 Dec;17(12):777-792. doi: 10.1038/nrn.2016.141. Epub 2016 Nov 10.
6
In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain.衰老大脑中的体内tau蛋白、淀粉样蛋白和灰质特征
J Neurosci. 2016 Jul 13;36(28):7364-74. doi: 10.1523/JNEUROSCI.0639-16.2016.
7
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography.脑脊液分析比正电子发射断层扫描更早检测到脑淀粉样β蛋白的积累。
Brain. 2016 Apr;139(Pt 4):1226-36. doi: 10.1093/brain/aww015. Epub 2016 Mar 2.
8
Gray matter network disruptions and amyloid beta in cognitively normal adults.认知正常成年人的灰质网络破坏与β淀粉样蛋白
Neurobiol Aging. 2016 Jan;37:154-160. doi: 10.1016/j.neurobiolaging.2015.10.015. Epub 2015 Oct 22.
9
Study of amyloid-β peptide functional brain networks in AD, MCI and HC.阿尔茨海默病、轻度认知障碍和健康对照者中β淀粉样蛋白肽功能性脑网络的研究。
Biomed Mater Eng. 2015;26 Suppl 1:S2197-205. doi: 10.3233/BME-151525.
10
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease.用于识别早期阿尔茨海默病的淀粉样蛋白PET和脑脊液生物标志物的详细比较。
Neurology. 2015 Oct 6;85(14):1240-9. doi: 10.1212/WNL.0000000000001991. Epub 2015 Sep 9.